Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
LTGO

Latigo Biotherapeutics (LTGO) stock: insider trades, news & valuation

Net buying
Close · Oct 9, 2026 $16.00 +8.2% on the day -12.3% over 12 months 52-week range $14.79 – $25.00

Share price and insider trades

LTGO closeInsider buyInsider sale
1015202530SepOctBought $5,040,000 on 2026-08-10 · Foresite Capital Fund Vi Lp, James B. Tananbaum
Bought, 12 months$5.0M
Sold, 12 months$0
Insiders buying2
Insiders selling0

Latigo Biotherapeutics insider trading at a glance (Oct 9, 2026): in the past 12 months, 2 insiders bought $5.0M and 0 sold $0 of LTGO stock on the open market.

LTGO insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q3 2026: $5.0M bought (2 trades)$5.0MQ3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026$5.0M2—0

Valuation, profit and volume

P/E (trailing)n/aSector median —
Market value— 
Profit margin—Revenue growth —
Volume vs. 50-day—Last 5 sessions
Insiders' paper profit−$560KOn all tracked purchases -11.1%

Summary

Over the past 12 months, 2 Latigo Biotherapeutics, Inc. insiders reported open-market purchases totaling $5.0M, while 0 insiders reported sales totaling $0. Among insiders with enough purchase history to measure, James B. Tananbaum (Director) has the highest Insider Score at 100.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Aug 10SEC James B. TananbaumDirector Buy 140,0002,008,024 held (+7%) $18.00 $2.5M -11.1% 100
Aug 10SEC Foresite Capital Fund Vi Lp10% Owner Buy 140,0002,008,024 held (+7%) $18.00 $2.5M -11.1% —

Insiders at Latigo Biotherapeutics, Inc.

InsiderBoughtSoldLast filingScore
James B. TananbaumDirector $2.5M — Aug 10, 2026 100
Foresite Capital Fund Vi Lp10% Owner $2.5M — Aug 10, 2026 —

LTGO stock: common questions

Are Latigo Biotherapeutics, Inc. insiders buying LTGO stock?

In the past 12 months, 2 insiders reported open-market purchases of LTGO worth $5.0M. The latest was Director James B. Tananbaum bought $2.5M of LTGO at $18.00 — first open-market purchase in our records.

Are Latigo Biotherapeutics, Inc. insiders selling LTGO stock?

0 insiders reported sales worth $0 over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is LTGO's 52-week range?

Over the past year LTGO has traded between $14.79 and $25.00. It last closed at $16.00 on Oct 9, 2026.